Articles about 'Chris Abell'

University of Cambridge portfolio company Astex Pharmaceuticals is to be acquired by a Japanese company in order to accelerate the development of new cancer treatments.

A new, single-step method of fabricating microcapsules, which have potential commercial applications in industries including medicine, agriculture and diagnostics, has been developed by researchers at the University of Cambridge. The findings are published Friday (10 February) in the journal Science.

Cambridge scientists are employing fragment-based drug discovery approaches - a technique that involves "growing" potent drugs from tiny chemical fragments - to tackle tuberculosis and cancer.

An innovative new project spearheaded by Cambridge Enterprise Ltd and researchers in the Department of Chemistry is taking a proactive approach to intellectual property (IP) and commercialisation.